Open-Ended HMO

An Open-Ended HMO is a type of Health Maintenance Organization (HMO) that allows members to receive care from providers outside of the network, but at a higher cost than in-network care. Here are some key features of Open-Ended HMOs:

  • In-network and out-of-network coverage: Members can receive care from both in-network and out-of-network providers. However, out-of-network care may not be covered or may be subject to higher cost-sharing requirements.

  • Primary care physician requirement: Members are typically required to choose a primary care physician (PCP) who serves as a gatekeeper to specialty care.

  • Lower out-of-pocket costs for in-network care: Members generally have lower out-of-pocket costs for in-network care than for out-of-network care.

  • Provider network limitations: Members must stay within the plan's provider network to receive in-network care. The network may be smaller than other types of HMOs.

Example: Let's say that a person is enrolled in an Open-Ended HMO and needs to see a specialist. They can choose to see a specialist within the network and pay lower out-of-pocket costs, or they can choose to see an out-of-network specialist and pay higher costs. The person would also need to choose a PCP and get a referral to see a specialist.

In this example, the Open-Ended HMO offers members the flexibility to receive care from out-of-network providers if they choose, but at a higher cost than in-network care. Members must still stay within the network to receive the lowest out-of-pocket costs, and must have a PCP and referral to see a specialist.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.